Developing and Validating a Survival Prediction Model for NSCLC Patients Through Distributed Learning Across 3 Countries

被引:98
作者
Jochems, Arthur [1 ]
Deist, Timo M. [1 ]
El Naqa, Issam [2 ]
Kessler, Marc [2 ]
Mayo, Chuck [2 ]
Reeves, Jackson [2 ]
Jolly, Shruti [2 ]
Matuszak, Martha [2 ]
Ten Haken, Randall [2 ]
van Soest, Johan [1 ]
Oberije, Cary [1 ]
Faivre-Finn, Corinne [3 ]
Price, Gareth [3 ]
de Ruysscher, Dirk [1 ]
Lambin, Philippe [1 ]
Dekker, Andre [1 ]
机构
[1] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Radiat Oncol MAASTRO, Maastricht, Netherlands
[2] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA
[3] Univ Manchester, Manchester Acad Hlth Sci Ctr, Christie NHS Fdn Trust, Manchester, Lancs, England
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 02期
基金
欧盟地平线“2020”; 欧洲研究理事会;
关键词
CELL LUNG-CANCER; RECURSIVE PARTITIONING ANALYSIS; ONCOLOGY GROUP RTOG; GROSS TUMOR VOLUME; RADIATION-THERAPY; EXTERNAL VALIDATION; PROGNOSTIC-FACTORS; HEALTH-CARE; 2-YEAR SURVIVAL; DOSE-ESCALATION;
D O I
10.1016/j.ijrobp.2017.04.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Tools for survival prediction for non-small cell lung cancer (NSCLC) patients treated with chemoradiation or radiation therapy are of limited quality. In this work, we developed a predictive model of survival at 2 years. The model is based on a large volume of historical patient data and serves as a proof of concept to demonstrate the distributed learning approach. Methods and Materials: Clinical data from 698 lung cancer patients, treated with curative intent with chemoradiation or radiation therapy alone, were collected and stored at 2 different cancer institutes (559 patients at Maastro clinic (Netherlands) and 139 at Michigan university [ United States]). The model was further validated on 196 patients originating from The Christie (United Kingdon). A Bayesian network model was adapted for distributed learning (the animation can be viewed at https://www.youtube.com/watch?v=ZDJFOxpwqEA). Two-year posttreatment survival was chosen as the endpoint. The Maastro clinic cohort data are publicly available at https://www.cancerdata.org/publication/developing-and-validating-survival-prediction-model-nsclc-patients-through-distributed, and the developed models can be found at www.predictcancer.org. Results: Variables included in the final model were T and N category, age, performance status, and total tumor dose. The model has an area under the curve (AUC) of 0.66 on the external validation set and an AUC of 0.62 on a 5-fold cross validation. A model based on the T and N category performed with an AUC of 0.47 on the validation set, significantly worse than our model (P<.001). Learning the model in a centralized or distributed fashion yields a minor difference on the probabilities of the conditional probability tables (0.6%); the discriminative performance of the models on the validation set is similar (P=.26). Conclusions: Distributed learning from federated databases allows learning of predictive models on data originating from multiple institutions while avoiding many of the data-sharing barriers. We believe that distributed learning is the future of sharing data in health care. (C) 2017 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:344 / 352
页数:9
相关论文
共 54 条
[1]   Rapid-Learning System for Cancer Care [J].
Abernethy, Amy P. ;
Etheredge, Lynn M. ;
Ganz, Patricia A. ;
Wallace, Paul ;
German, Robert R. ;
Neti, Chalapathy ;
Bach, Peter B. ;
Murphy, Sharon B. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (27) :4268-4274
[2]  
[Anonymous], 2013, NONPARAMETRIC STAT M
[3]  
[Anonymous], ADV DRUG DELIV REV
[4]   Prognostic factors for survival in Stage III non-small-cell lung cancer treated with definitive radiation therapy: Impact of tumor volume [J].
Basaki, K ;
Abe, Y ;
Aoki, M ;
Kondo, H ;
Hatayama, Y ;
Nakaji, S .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (02) :449-454
[5]   CONSTRUCTING CONFIDENCE SETS USING RANK STATISTICS [J].
BAUER, DF .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1972, 67 (339) :687-690
[6]   Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973) [J].
Belderbos, Jose ;
Uitterhoeve, Lon ;
van Zandwijk, Nico ;
Belderbos, Huub ;
Rodrigus, Patrick ;
van de Vaart, Paul ;
Belderbos, Huub ;
Rodrigus, Patrick ;
van de Vaart, Paul ;
Price, Allan ;
van Walree, Nico ;
Legrand, Catherine ;
Dussenneh, Sonia ;
Bartelink, Harry ;
Giaccone, Giuseppe ;
Koning, Caro .
EUROPEAN JOURNAL OF CANCER, 2007, 43 (01) :114-121
[7]   Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy [J].
Berghmans, T ;
Lafitte, JJ ;
Thiriaux, J ;
VanHoutte, P ;
Lecomte, J ;
Efremidis, A ;
Koumakis, G ;
Giner, V ;
Richez, M ;
Corhay, JL ;
Wackenier, P ;
Lothaire, P ;
Mommen, P ;
Ninane, V ;
Sculier, JP .
LUNG CANCER, 2004, 45 (03) :339-348
[8]   Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma [J].
Bradley, JD ;
Ieumwananonthachai, N ;
Purdy, JA ;
Wasserman, TH ;
Lockett, MA ;
Graham, MV ;
Perez, CA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (01) :49-57
[9]   Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study [J].
Bradley, Jeffrey D. ;
Paulus, Rebecca ;
Komaki, Ritsuko ;
Masters, Gregory ;
Blumenschein, George ;
Schild, Steven ;
Bogart, Jeffrey ;
Hu, Chen ;
Forster, Kenneth ;
Magliocco, Anthony ;
Kavadi, Vivek ;
Garces, Yolanda I. ;
Narayan, Samir ;
Iyengar, Puneeth ;
Robinson, Cliff ;
Wynn, Raymond B. ;
Koprowski, Christopher ;
Meng, Joanne ;
Beitler, Jonathan ;
Gaur, Rakesh ;
Curran, Walter, Jr. ;
Choy, Hak .
LANCET ONCOLOGY, 2015, 16 (02) :187-199
[10]   Prognostic factors in non-small cell lung cancer - A decade of progress [J].
Brundage, MD ;
Davies, D ;
Mackillop, WJ .
CHEST, 2002, 122 (03) :1037-1057